Introduction to Ocular and Otic Pharmacology
The eye and ear possess unique anatomical barriers that restrict drug delivery. The blood-ocular barrier, composed of tight junctions in the retinal capillary endothelium and the pigment epithelium, prevents many systemically administered drugs from reaching therapeutic concentrations inside the eye. Consequently, topical administration via eye drops or ointments is preferred for localized conditions.
Similarly, the tympanic membrane protects the middle ear, meaning topical ear drops only treat external ear canal pathologies unless the membrane is perforated. Understanding these barriers explains why systemic doses for eye or ear infections are often much higher than topical applications, or why systemic side effects can still occur due to systemic absorption through the nasolacrimal duct.
Pharmacotherapy of Glaucoma
Glaucoma is characterized by elevated intraocular pressure (IOP) that damages the optic nerve. Drug therapy aims to either decrease aqueous humor production or increase its outflow.
- Prostaglandin analogues (e.g., latanoprost): Increase uveoscleral outflow of aqueous humor. They are often first-line due to once-daily dosing and high efficacy, though they can cause permanent brown pigmentation of the iris.
- Beta-blockers (e.g., timolol): Decrease aqueous humor production by the ciliary body. Contraindicated in patients with asthma or severe bradycardia.
- Alpha-2 agonists (e.g., brimonidine): Both decrease production and increase outflow of aqueous humor.
- Carbonic anhydrase inhibitors (e.g., dorzolamide): Inhibit enzyme carbonic anhydrase in the ciliary body, reducing aqueous humor secretion.
- Cholinergic agonists / Miotics (e.g., pilocarpine): Contract the ciliary muscle, opening the trabecular meshwork to increase aqueous outflow.
Mydriatics, Cycloplegics, and Miotics
These agents alter pupil size and ciliary muscle tone for diagnostic examinations or specific therapeutic interventions.
- Mydriatics (e.g., phenylephrine): Stimulate the radial muscle of the iris to cause pupillary dilation (mydriasis) without affecting accommodation.
- Cycloplegics (e.g., atropine, cyclopentolate): Paralyze the ciliary muscle, blocking accommodation (cycloplegia) and dilating the pupil. Used during refraction tests in children and for treating uveitis by resting the eye.
- Miotics (e.g., pilocarpine): Constrict the pupil (miosis) by stimulating the sphincter muscle of the iris.
A common clinical mistake is failing to warn patients that cycloplegics cause blurred near vision and photophobia lasting several hours, making driving dangerous.
Anti-infective and Anti-inflammatory Ophthalmic Agents
Infections and inflammatory conditions of the external eye require targeted antimicrobial or anti-inflammatory therapy.
- Antibacterial drops and ointments (e.g., ciprofloxacin, tetracycline, gentamicin): Treat bacterial conjunctivitis, keratitis, and corneal ulcers. Nurses must ensure patients complete the full course even if symptoms resolve quickly.
- Antiviral agents (e.g., ganciclovir, acyclovir): Used for viral keratitis caused by herpes simplex virus.
- Antifungal agents (e.g., natamycin): Used for fungal keratitis, often associated with agricultural trauma involving plant matter.
- Corticosteroids (e.g., dexamethasone, prednisolone): Suppress inflammation and scarring. Long-term use carries significant risks of inducing secondary glaucoma and cataracts.
- NSAIDs (e.g., ketorolac): Reduce post-operative inflammation without steroid-related pressure spikes.
Local Anesthetics and Diagnostic Agents
Diagnostic procedures and minor ocular surgeries require topical anesthetics and staining agents.
- Local anesthetics (e.g., tetracaine, proparacaine): Provide rapid, short-acting corneal and conjunctival anesthesia for tonometry, foreign body removal, or suture removal.
- Diagnostic dyes (e.g., fluorescein sodium): Instilled into the conjunctival sac to highlight corneal abrasions, epithelial defects, or poorly fitting contact lenses under cobalt blue light.
Nurses must teach patients never to rub their eyes while under the influence of topical anesthetics, as the lack of sensation prevents them from realizing they are scratching or damaging the softened corneal epithelium.
Pharmacological Management of Otic Disorders
Otic preparations manage external ear infections, inflammation, and excessive cerumen accumulation.
- Anti-infective ear drops (e.g., ciprofloxacin with hydrocortisone, polymyxin B): Treat otitis externa (swimmer's ear). The addition of a steroid reduces swelling and itching.
- Antifungal ear drops (e.g., clotrimazole): Prescribed for otomycosis, a fungal infection common in humid environments.
- Cerumenolytics (e.g., hydrogen peroxide, docusate sodium drops): Soften and break up impacted earwax to facilitate easy irrigation or manual removal.
Never instill otic drops if a perforated tympanic membrane is suspected, unless the medication is specifically verified as non-ototoxic and safe for middle ear structures, to prevent inner ear damage or severe vertigo.
Administration Techniques and Nursing Implications
Correct administration ensures maximum drug efficacy and minimizes systemic adverse effects.
- Eye Drop Technique: Tilt the head back, pull down the lower lid to form a pocket, instill drops into the conjunctival sac, and release the eyelid. Apply gentle pressure to the nasolacrimal duct (punctal occlusion) for 1 to 2 minutes to prevent systemic absorption.
- Ointment Technique: Apply a thin ribbon of ointment along the inside of the lower conjunctival lid from the inner to outer canthus. Instruct the patient that vision will blur temporarily.
- Ear Drop Technique: For adults, pull the pinna up and back; for children under three, pull the pinna down and straight back. Keep the patient's head tilted for a few minutes to ensure the medication coats the canal.
Patient Education and Safety Considerations
Nurses play a critical role in teaching safe handling and storage of ophthalmic and otic preparations in community and clinical settings across Nigeria.
Patients must avoid touching the dropper tip to any surface, including fingers, eyelashes, or skin, to prevent contaminating the entire bottle with bacteria or fungi. Medications should be stored according to manufacturer guidelines, as tropical heat can degrade active compounds.
Furthermore, sharing eye or ear drops among family members must be strongly discouraged, as this practice easily transmits infectious conjunctivitis or otitis externa from person to person.